Cyteir Therapeutics attracts $80m Series C

Cyteir Therapeutics, a developer of next-generation synthetic lethal therapies for cancer, has raised $80 million in Series C financing.

Cyteir Therapeutics, a developer of next-generation synthetic lethal therapies for cancer, has raised $80 million in Series C financing. RA Capital Management led the round.

Source: Press Release